Tata India Pharma & Healthcare Fund

Tata Mutual Fund · Sectoral / Thematic · Regular Idcw · AMFI 135809 · ISIN INF277K017A7
NAV₹32.634720 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio2.40%
Growth Score—

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund——————————
NIFTY Pharma TRI+10.85%+7.49%+14.67%+25.66%+25.86%+22.31%+16.87%———
Category middle+6.85%+0.56%+8.14%+3.99%+3.08%+13.26%+11.84%+16.64%+14.59%—

Risk (36 months)

Volatility—
Sharpe—
Sortino—
Beta—
Alpha—
Deepest fall—
1-year periods with a loss—
5Y SIP XIRR—

Top holdings (31 Oct 2026)

SUN PHARMACEUTICAL INDUSTRIES LTD7.89%
ABBOTT INDIA LTD5.66%
DIVI LABORATORIES LTD5.41%
HEALTHCARE GLOBAL ENTERPRISES LTD5.25%
DR REDDYS LABORATORIES LTD5.14%
TORRENT PHARMACEUTICALS LTD4.73%
APOLLO HOSPITALS ENTERPRISE LTD4.55%
MAX HEALTHCARE INSTITUTE LTD4.28%
RAINBOW CHILDRENS MEDICARE LTD4.02%
SAI LIFE SCIENCES LTD3.22%
SYNGENE INTERNATIONAL LTD3.17%
PROCTER & GAMBLE HEALTH LTD3.15%

Sectors

Pharmaceuticals & Biotechnology63.7%
Healthcare Services25.5%
Fertilizers & Agrochemicals4.2%
Chemicals & Petrochemicals3.5%
Personal Products1.2%
Food Products1.1%
Healthcare Equipment & Supplies0.5%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.